Provectus Biopharmaceuticals

PVCT · OTC

$0.0499+$0.001 (+2.04%)TodayMarket closed ·
Prev close $0.0489

Who owns PVCT

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 7.5% of PVCT’s shares.

  • Morris (Jeffrey Allen)4.4%
  • Wachter (Eric A)1.6%
  • Pershing (Edward V CPA)0.8%
  • Raines (Heather)0.4%
  • Next 6 largest institutions0.4%
  • All other shareholders92.5%
Top institutional holders of PVCT
HolderShares% of shares
Morris (Jeffrey Allen)18.50M4.40%
Wachter (Eric A)6.65M1.58%
Pershing (Edward V CPA)3.16M0.75%
Raines (Heather)1.72M0.41%
Rodrigues (Dominic)1.08M0.26%
Lacy (John III)200.00K0.05%
Bailey (Webster)145.53K0.03%
Home Federal Bank of Tennessee100.00K0.02%
Gearhart & Associates19.62K0.00%
Financial Symmetry Inc10.19K0.00%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of PVCT in the last 6 months.

Latest PVCT insider transactions
InsiderTypeSharesValue
Pershing EdwardOption exercise22.61K—
Pershing EdwardOption exercise13.22K—
Pershing EdwardOption exercise13.22K—
Pershing EdwardOption exercise13.22K—
Pershing EdwardOption exercise11.33K—
Pershing EdwardOption exercise11.33K—
Pershing EdwardAward45.86K—
Pershing EdwardOption exercise9.44K—
Pershing EdwardOption exercise32.09K—
Pershing EdwardOption exercise22.65K—

Short interest

Settled Sep 30, 2026

Shares short
801.17K
Days to cover
4.82
% of shares outstanding
0.19%
Average daily volume
166.37K
Change since last report
+0.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.